This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (28)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

A. Marshall McBean, MD, MSc; J. Daniel Babish, MPH; Ronald Prihoda

Arch Intern Med. 1991;151(10):2009-2016.

Abstract
Since July 1981, Medicare has paid for the administration of pneumococcal vaccine without regard to the deductible limit and without copayment. Claims submitted to Medicare for reimbursement for the 4-year period from 1985 through 1988 for a 5% sample of elderly Medicare beneficiaries enrolled in part B who were not members of health maintenance organizations were analyzed. Vaccine was administered to an estimated 1 392 840 beneficiaries (5.34%). The total estimated cost to Medicare was $14.3 million, or approximately $10.27 per dose. Crude 4-year rates indicated that white persons were much more likely to be immunized than black persons (5.60% vs 2.94%). Persons 70 through 84 years of age had higher immunization rates than either younger or older beneficiaries. The number of immunizations given peaked in 1986 and declined thereafter. A variety of vaccination strategies that may raise the immunization level in the elderly have been developed. The broad implementation of successful strategies will be important if the goal of a 60% immunization level in the elderly by the year 2000 is to be reached.

(Arch Intern Med. 1991;151:2009-2016)

Author Affiliations
From the Epidemiology Branch, Division of Beneficiary Studies, Office of Research (Dr McBean and Mr Babish), and the Bureau of Data Management Strategies (Mr Prihoda), Health Care Financing Administration, Baltimore, Md.

Footnotes
Accepted for publication April 8, 1991.

Reprint requests to Epidemiology Branch, Office of Research, 2504 Oak Meadows Bldg, Health Care Financing Administration, 6325 Security Blvd, Baltimore, MD 21207 (Dr McBean).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Delivery of Preventive Services to Older Adults by Primary Care Physicians
Pham et al.
JAMA 2005;294:473-481.
ABSTRACT | FULL TEXT  

Immune Function and Vaccine Responses in Healthy Advanced Elderly Patients
Carson et al.
Arch Intern Med 2000;160:2017-2024.
ABSTRACT | FULL TEXT  

Cost-effectiveness of Vaccination Against Pneumococcal Bacteremia Among Elderly People
Sisk et al.
JAMA 1997;278:1333-1339.
ABSTRACT  

Adult Bacteremic Pneumococcal Pneumonia in a Community Teaching Hospital, 1992-1996n: A Detailed Analysis of 108 Cases
Watanakunakorn and Bailey
Arch Intern Med 1997;157:1965-1971.
ABSTRACT  

Reactions Following Administration of Influenza Vaccine Alone or With Pneumococcal Vaccine to the Elderly
Honkanen et al.
Arch Intern Med 1996;156:205-208.
ABSTRACT  

Race-Specific Differences in Influenza Vaccination Levels Among Medicare Beneficiaries-United States, 1993
JAMA 1995;273:449-451.
 

Pneumococcal Vaccine After 15 Years of Use: Another View
Fedson et al.
Arch Intern Med 1994;154:2531-2535.
ABSTRACT  

Prevention of Respiratory Infections in Adults: Influenza and Pneumococcal Vaccines
Fiebach and Beckett
Arch Intern Med 1994;154:2545-2557.
ABSTRACT